Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00052117 | Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens | PHASE2 | COMPLETED | 300 | — | — | Jan 1, 2003 | May 1, 2005 | Oct 10, 2007 | - | — |
| Name | Type | Description |
|---|---|---|
| capravirine | DRUG | - |
| Kaletra | DRUG | - |
| 2 NRTIs | DRUG | - |
Inclusion Criteria: * HIV-infected male or female at least 18 years of age * HIV RNA level \>1000 copies/mL at screening * Subject has failed regimens that included at least 1 protease inhibitor but not more than 3 protease inhibitors, at least 1 nonnucleoside reverse transcriptase inhibitor, and l...